TORSKAL is an international biotech/medtech company, a pioneer of green nanotechnology. We design disruptive gold nanoparticles for cancer therapy from green chemistry. We are committed to the development of a new generation of non-toxic and eco-friendly nanomaterials for the treatment of surface and deep cancers by green chemistry. We have discovered an innovative, green, and patented way of producing gold nanoparticles, leveraging Indian Ocean endemic plants, that have many applications in health. Main project: the Nanotheranostics Project (NT1), a treatment for skin cancer using near-infrared (IR) radiation-induced plasmonic phototherapy Deep Cancer program (NT2 & NT3), which aims to develop new nanotheranostics for the treatment of deep cancers such as prostate, bladder and pancreatic cancers We also sell our unique gold nanoparticles through our website's e-commerce platform which has a wide range of applications in diagnostics, research, industry, and others. TORSKAL is currently located in Europe (France, La Réunion) & China
There is no investment information
No recent news or press coverage available for TORSKAL.